The inhibition of epidermal growth factor receptor signaling by hexagonal selenium nanoparticles modified by SiRNA. (Q50488952)

14 March 2018

title

The inhibition of epidermal growth factor receptor signaling by hexagonal selenium nanoparticles modified by SiRNA. (English)

1 reference

14 March 2018

1 reference

L Kamrani Moghaddam

1 reference

14 March 2018

S Ramezani Paschepari

1 reference

14 March 2018

M A Zaimy

1 reference

14 March 2018

A Abdalaian

1 reference

14 March 2018

A Jebali

1 reference

14 March 2018

publication date

9 September 2016

1 reference

14 March 2018

published in

Cancer Gene Therapy

1 reference

14 March 2018

volume

1 reference

14 March 2018

issue

1 reference

14 March 2018

page(s)

321-325

1 reference

14 March 2018

Review of epidermal growth factor receptor biology

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2016.38

A comprehensive pathway map of epidermal growth factor receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2016.38

Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2016.38

Cell signalling: growth factors and tyrosine kinase receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2016.38

Early signaling dynamics of the epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2016.38

Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2016.38

Signalling change: signal transduction through the decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2016.38

Epidermal growth factor receptor (EGFR) signaling regulates global metabolic pathways in EGFR-mutated lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2016.38

carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (cad) regulates Notch signaling and vascular development in zebrafish

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2016.38

Effect of nanoparticle conjugation on gene silencing by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2016.38

Ligand-induced, receptor-mediated dimerization and activation of EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2016.38

In vitro and in vivo evaluation of a new nanocomposite, containing high density polyethylene, tricalcium phosphate, hydroxyapatite, and magnesium oxide nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2016.38

The cytotoxicity of silver nanoparticles coated with different free fatty acids on the Balb/c macrophages: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2016.38

Epidermal growth factor receptor (EGFR) signaling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2016.38

EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2016.38

The Next Wave of EGFR Tyrosine Kinase Inhibitors Enter the Clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2016.38

Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-Analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2016.38

The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer

21 January 2018

1 reference

12 December 2020

The toxic effects of silver nanoparticles on blood mononuclear cells

1 reference

12 December 2020

Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa).

1 reference

12 December 2020

Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/In

1 reference

12 December 2020

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

1 reference

12 December 2020

Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins

1 reference

12 December 2020

Identifiers

DOI

10.1038/CGT.2016.38

1 reference

14 March 2018

1 reference

14 March 2018